Angel Matthew

CIK: 0001931356•President and CEO

OfficerDirector

Primary company: Eterna Therapeutics Inc. (ERNA)

Angel Matthew is a corporate insider (President and CEO) at Eterna Therapeutics Inc. (ERNA) filing SEC Form 4 transactions. 4 transactions. Source: SEC EDGAR.

Total Transactions

Total Buy Value

Total Sell Value

Net Activity

Last Transaction

Mar 2026

Companies

Transaction History

Filter:

Source: SEC EDGAR Form 4 insider transaction filings.

Company	Type	Shares	Price	Value	Shares After	Date	SEC
Tempest Therapeutics, Inc. TPST	Purchase	231,482	$2.16	$500K	231,482	3/24/2026 Filed: 3/24/2026	Filing →
Tempest Therapeutics, Inc. TPST	Award	269,621	$2.38	$642K	269,621	2/4/2026 Filed: 2/4/2026	Filing →
Eterna Therapeutics Inc. ERNA	Award	132,003	$0.00	$0	132,003	1/12/2023 Filed: 1/13/2023	Filing →
Brooklyn ImmunoTherapeutics, Inc. BTX	Award	2,487,003	$0.00	$0	2,487,003	8/1/2022 Filed: 8/3/2022	Filing →

Tempest Therapeutics, Inc.

TPST

Type

Purchase

231,482

Price

$2.16

Value

$500K

Tempest Therapeutics, Inc.

TPST

Type

Award

269,621

Price

$2.38

Value

$642K

Eterna Therapeutics Inc.

ERNA

Type

Award

132,003

Price

$0.00

Value

Brooklyn ImmunoTherapeutics, Inc.

BTX

Type

Award

2,487,003

Price

$0.00

Value

AI Agent

Try asking...